Dose Escalation Study of ARQ 621 in Adult Patients With Metastatic Solid Tumors and Hematologic Malignancies

Name: Dose Escalation Study of ARQ 621 in Adult Patients With Metastatic Solid Tumors and Hematologic Malignancies
Published: 2009
License: Public Domain

ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) · 2009

ClinicalTrials.gov · Datasets · License: Public Domain · 2009

Open Source ↗

acute chronic leukemia lymphoma multiple

metastatic solid tumors, refractory/relapsed hematologic malignancies, metastatic, hematologic, malignancy, multiple, myeloma, malignant, lymphoma, chronic, lymphocytic, leukemia, acute

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 802018
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.